NCBI PubMed Central
open access
Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Investigating the use of oligonucleotides for the treatment of muscular dystrophy#1148728
- Macrolides: a potential treatment for myotonic dystrophy type 1#483927
- FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook#314819
- DELIVERY STRATEGIES FOR OLIGONUCLEOTIDE-BASED THERAPIES#929277
- Investigating the potential role of CDK13 in the transcription and stability of mutant DMPK mRNA in myotonic dystrophy type 1#990179
Record · ID 312529
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive